Emily Fairbairn

Director at IN8Bio

Emily Wang Fairbairn has served as a member of the board of directors since July 2021. Since 2018, she has also served as the Chair of the Board at Movano. Ms. Fairbairn has spent the majority of her career in executive leadership and management positions and as a seasoned investor and mentor to early-stage companies. In 1999, Ms. Fairbairn was Co-Founder and CEO of Ascent Capital, a multi-billion-dollar hedge fund, which she ran until 2018. The firm focused on managing assets for institutional clients such as pensions, endowments, and public companies. Prior to Ascend Capital, she spent a decade building a successful practice of equity portfolio construction and financial planning for high net worth clients for Merrill Lynch. Today, Ms. Fairbairn is an active investor, and since 2017 serving on the founding board of the MIT Sandbox Fund to mentor aspiring entrepreneurs. She is also a dedicated advocate of funding research for a realizable diagnostic and cure for Lyme+, which affects around 500,000 people annually in the U.S. Emily holds a Bachelor of Science degree from California State Polytechnic University in Chemical Engineering.

Timeline

  • Director

    Current role